Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive pulmonary disease characterized by aberrant tissue remodeling, formation of scar tissue within the lungs and continuous loss of lung function. The areas of fibrosis seen in lungs of IPF patients share many features with normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Atanasova, Elena, Milosevic, Dragana, Bornschlegl, Svetlana, Krucker, Karen P., Jacob, Eapen K., Carmona Porquera, Eva M., Anderson, Dagny K., Egan, Ashley M., Limper, Andrew H., Dietz, Allan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802496/
https://www.ncbi.nlm.nih.gov/pubmed/35101101
http://dx.doi.org/10.1186/s13287-021-02692-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802496/
https://www.ncbi.nlm.nih.gov/pubmed/35101101
http://dx.doi.org/10.1186/s13287-021-02692-0

Ejemplares similares